Will T-cell therapy for cancer ever be a standard of care?
Cellular therapies for cancer are showing increasing efficacy but their introduction as a 'standard of care' for these disorders is hampered by technical, regulatory and financial concerns. This review identifies some of the major problems and suggests potential solutions.
Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital, Houston, TX 77030, USA. mbrenner@bcm.edu
M K
MK
Brenner
D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods* / Q000592:standards; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D059039:Standard of Care; D013601:T-Lymphocytes / Q000276:immunology* / Q000637:transplantation*